RB enjoys OTC growth ‘ahead of the market’
This article was originally published in OTC Bulletin
Executive Summary
Reckitt Benckiser’s (RB’s) OTC business performed “materially ahead of the market” in the third-quarter of 2018, chief executive Rakesh Kapoor informed analysts on the firm’s earnings call.